// App-Quantinova.ai

9042 : Rociletinib-associated cataracts in EGFR-mutant NSCLC.

Researchers

Presenter

  • Zofia Piotrowska

Principal Investigators

  • Erica Liu

  • Jennifer Logan

  • Jessica Chow

  • Fasika A Woreta

  • Alona Muzikansky

  • Lisa Stober

  • Alexandra Carly Wanat

  • Kelly Goodwin

  • Christopher G. Azzoli

  • Jennifer S. Temel

  • Rebecca Suk Heist

  • Alice Tsang Shaw

  • Jeffrey A. Engelman

  • Kamden Kopani

  • Lecia V. Sequist

Medical Centers

  • Massachusetts General Hospital Cancer Center, Boston, MA

  • Tufts University School of Medicine, Boston, MA

  • Massachusetts General Hospital, Boston, MA

  • Yale University School of Medicine, New Haven, CT

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Massachusetts General Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hyperglycemia

  • Cataract

  • Non Small Cell Lung cancer

Biomarkers

  • Hemoglobin A1c

Drug/Treatment

  • rociletinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I/II

Study Id's

  • NCT01526928

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved